GlassScriptPhysician profile
Harvinder Singh Arora
NPI 1891922134
$22,826.24
in general payments reported to CMS, 2019-2025
35 companies · $841 in 2025
The $841 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,316 · 2020: $1,053 · 2021: $4,571 · 2022: $3,965 · 2023: $3,676 · 2024: $7,405 · 2025: $841.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,964 · Food and Beverage: $4,857 · Education: $99.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,964.24 |
| Food and Beverage | $4,857.33 |
| Education | $99.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $9,077.80 | 2019-2025 | Aveir, Mitraclip, Perclose Prostyle |
| Medtronic, INC. | $5,067.09 | 2021-2024 | Venaseal, Corevalve Evolut R, Mc3 Nautilus(Tm) Ecmo Oxygenator |
| Abiomed | $1,287.16 | 2019-2025 | Impella |
| Boston Scientific Corporation | $1,121.36 | 2022-2025 | Watchman Flx, Peripheral Rotalink Plus, Versacross Access Solution |
| Medical Device Business Services, INC. | $985.55 | 2023 | Carto 3 |
| Inari Medical, INC. | $897.97 | 2019-2021 | |
| Baylis Medical Company INC | $861.41 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $612.64 | 2019-2024 | Brilinta, Farxiga |
| Edwards Lifesciences Corporation | $427.60 | 2019-2024 | Sapien 3 Ultra Resilia |
| Novartis Pharmaceuticals Corporation | $356.47 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $343.88 | 2019-2024 | Xarelto |
| Terumo Medical Corporation | $241.25 | 2022 | |
| Penumbra, INC. | $210.46 | 2022-2024 | Penumbra System, Indigo System |
| Medtronic Vascular, INC. | $192.68 | 2020 | |
| Shockwave Medical, INC | $161.81 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $139.10 | 2019 | |
| Cardiovascular Systems INC. | $118.78 | 2019-2021 | |
| Intuitive Surgical, INC. | $117.12 | 2025 | |
| Biosense Webster, INC. | $101.61 | 2023-2025 | Carto 3, Nuvision Ice Catheter |
| Angiodynamics, INC. | $94.02 | 2024 | Auryon Laser System 100-120 Vac |
| Amgen INC. | $81.23 | 2019-2024 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $59.43 | 2019-2024 | Camzyos |
| Merck Sharp & Dohme LLC | $35.41 | 2024 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $31.44 | 2020-2024 | Lifevest |
| Merit Medical Systems INC | $28.05 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.54 | 2024 | |
| Cvrx, INC. | $24.63 | 2024 | Barostim Neo System |
| Kestra Medical Technology Services, INC. | $22.23 | 2024 | Assure Wcd |
| W. L. Gore & Associates, INC. | $18.01 | 2019 | |
| Pfizer INC. | $17.69 | 2022 | |
| Scpharmaceuticals INC. | $15.33 | 2024 | |
| Philips North America LLC | $13.59 | 2025 | Ecc Solutions |
| Ekos Corporation | $12.95 | 2019 | |
| Sanofi-Aventis U.S. LLC | $12.50 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $12.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harvinder Arora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.